𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cell death and apoptosis regulating proteins in Parkinson’s disease – a cautionary note

✍ Scribed by U. Wüllner; J. Kornhuber; M. Weller; J. B. Schulz; P.-A. Löschmann; P. Riederer; T. Klockgether

Publisher
Springer-Verlag
Year
1999
Tongue
English
Weight
379 KB
Volume
97
Category
Article
ISSN
0001-6322

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In situ detection of fragmented dna (tun
In situ detection of fragmented dna (tunel assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note
✍ Bettina Grasl Kraupp; Branislav Ruttkay-Nedecky; Helga Koudelka; Krystyna Bukows 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 545 KB

Detection of DNA fragments in situ using the terminal deoxyribonucleotidyl transferase (TDTbmediated dUTP-digoxigenin nick end labeling (TUNEL) assay is increasingly applied to investigate active cell death (apoptosis). We studied the specificity of the assay i n well-defined models of apoptosis and

Levodopa induces apoptosis in cultured n
Levodopa induces apoptosis in cultured neuronal cells—A possible accelerator of nigrostriatal degeneration in Parkinson's disease?
✍ Ilan Ziv; Rina Zilkha-Falb; Daniel Offen; Anat Shirvan; Ari Barzilai; Dr. Eldad 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 856 KB

## Abstract Apoptosis is an active, intrinsic cell suicide program. We recently suggested that it may have a role in the death of nigrostriatal dopaminergic neurons in Parkinson's disease (PD). We now report that levodopa, the current major therapy for PD, is a potent inducer of apoptosis in cultur

The MAGE proteins: Emerging roles in cel
The MAGE proteins: Emerging roles in cell cycle progression, apoptosis, and neurogenetic disease
✍ Philip A. Barker; Amir Salehi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB

## Abstract Since the identification of the first MAGE gene in 1991, the MAGE family has expanded dramatically, and over 25 MAGE genes have now been identified in humans. The focus of studies on the MAGE proteins has been their potential for cancer immunotherapy, as a result of the finding that pep